REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 211 filers reported holding REGENXBIO INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,735,000 | +36.3% | 117,527 | -0.2% | 0.01% | +25.0% |
| Q4 2018 | $4,942,000 | -72.8% | 117,810 | -51.0% | 0.00% | -33.3% |
| Q3 2018 | $18,140,000 | +23.7% | 240,264 | +17.6% | 0.01% | -40.0% |
| Q2 2018 | $14,665,000 | +485.2% | 204,387 | +143.5% | 0.01% | +400.0% |
| Q1 2018 | $2,506,000 | +11.8% | 83,939 | +24.5% | 0.00% | +100.0% |
| Q4 2017 | $2,241,000 | -2.8% | 67,403 | -3.6% | 0.00% | -50.0% |
| Q3 2017 | $2,305,000 | +57.3% | 69,940 | -5.7% | 0.00% | +100.0% |
| Q2 2017 | $1,465,000 | +36.7% | 74,175 | +33.6% | 0.00% | 0.0% |
| Q1 2017 | $1,072,000 | -3.2% | 55,528 | -6.9% | 0.00% | 0.0% |
| Q4 2016 | $1,107,000 | +31.6% | 59,653 | -0.7% | 0.00% | 0.0% |
| Q3 2016 | $841,000 | +75.6% | 60,056 | +0.3% | 0.00% | – |
| Q2 2016 | $479,000 | +192.1% | 59,859 | +294.2% | 0.00% | – |
| Q1 2016 | $164,000 | -34.9% | 15,184 | 0.0% | 0.00% | – |
| Q4 2015 | $252,000 | – | 15,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |